Similar articles

• Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function.

  Gallon LG, Winoto J, Leventhal JR, Parker MA, Kaufman DB. Gallon LG, et al. Clin J Am Soc Nephrol. 2006 Sep;1(5):1029-38. doi: 10.2215/CJN.00790306. Epub 2006 Jul 6. Clin J Am Soc Nephrol. 2006. PMID: 17699323
• Strategies in immunosuppression after heart transplantation: is less better?

  Kobashigawa JA. Kobashigawa JA. Circ Heart Fail. 2011 Mar;4(2):111-3. doi: 10.1161/CIRCHEARTFAILURE.110.960690. Circ Heart Fail. 2011. PMID: 21406677 No abstract available.
• Mycofenolate mofetil-cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses.

  Remport A, Sasvári I, Toronyi E, Borka P, Lázár N, Járay J, Perner F. Remport A, et al. Transplant Proc. 2001 May;33(3):2302-3. doi: 10.1016/s0041-1345(01)01999-6. Transplant Proc. 2001. PMID: 11377537 Clinical Trial. No abstract available.
• [Improved immunosuppression leads to better kidney transplantations].

  Ekberg H. Ekberg H. Lakartidningen. 2012 Sep 26-Oct 9;109(39-40):1739-42. Lakartidningen. 2012. PMID: 23097879 Review. Swedish. No abstract available.
• Mycophenolate mofetil-based immunosuppressive minimization and withdrawal strategies in renal transplantation: possible risks and benefits.

  Meier-Kriesche HU. Meier-Kriesche HU. Curr Opin Nephrol Hypertens. 2006 Jun;15 Suppl 1:S1-5. doi: 10.1097/01.mnh.0000236065.75007.5e. Curr Opin Nephrol Hypertens. 2006. PMID: 16829733 Review.